A recent study demonstrated that treatment of hyperactive mice with psychostimulants and serotonergic agents produced a calming effect that was dependent on serotonergic neurotransmission and was not associated with any changes in extracellular dopamine levels. 1 The complex interaction between the serotonergic and dopaminergic neurotransmitter systems suggests that a balance between the two systems may be necessary for mediating hyperactive behaviour. Defects in serotonin system genes, therefore, may disrupt normal brain serotonin function causing an imbalance between these neurotransmitter systems leading to the development of attention deficit hyperactivity disorder (ADHD). Attention deficit hyperactivity disorder (ADHD) is a common childhood disruptive behavioral disorder affecting between 3-5% of school age children who display persistent patterns of inattention and hyperactivity/impulsivity causing impairment in academic, social, and emotional development. 2 ADHD children frequently exhibit a variety of other comorbid conditions such as learning disorder, mood disorder, and other disruptive behavior disorders including oppositional defiant disorder (ODD) and conduct disorder (CD).While the exact mechanisms for the disorder are unknown, research has suggested abnormalities in the catecholaminergic and serotonergic systems. Support for a catecholaminergic hypothesis has been based on evidence from neuroimaging studies which have suggested reduced functioning in frontal-striatal regions, whose pathways are rich in catecholamines, notably dopamine. 3 Furthermore, stimulant medications, such as methylphenidate (Ritalin™), whose primary site of action is the dopamine transporter, have shown widespread clinical success in the treatment of ADHD. The significant interaction between the dopaminergic and serotonergic systems, 4 however, suggests that dopamine dysfunction may not be the sole basis for the development of ADHD.Evidence for the serotonergic hypothesis began two decades ago when it was found that whole blood and serum serotonin (5-HT) concentrations were decreased in children with ADHD. 5,6 These results have been further supported by a recent study that also found a tendency towards low platelet serotonin in a sample of children with severe ADHD. 7 Additional support for a serotonin hypothesis is demonstrated by the moderate efficacy of several serotonin enhancing agents in the treatment of ADHD including selective serotonin reuptake inhibitors (SSRIs) 8 and certain selective monoamine oxidase inhibitors. 9 Several lines of evidence have indicated abnormal serotonergic function in children with disruptive behaviour disorders (ADHD, ODD, CD) who display marked problems with hyperactivity, impulsivity, and aggression. [10][11][12][13][14] Animal models of ADHD have also been useful in implicating a role for serotonin in the control of attention, impulsivity, and hyperactivity. Rodents that had poorer performance on a task measuring attention and impulsivity had a greater index of serotonin utilization in t...